Get the Stockscreener App
75.20
0.15%
0.11
After Hours:
75.37
0.17
+0.23%
Edwards Lifesciences Corp stock is traded at $75.20, with a volume of 4.84M.
It is up +0.15% in the last 24 hours and down -3.91% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
See More
Previous Close:
$75.09
Open:
$75.42
24h Volume:
4.84M
Relative Volume:
1.19
Market Cap:
$44.15B
Revenue:
$5.69B
Net Income/Loss:
$1.41B
P/E Ratio:
10.82
EPS:
6.95
Net Cash Flow:
$577.90M
1W Performance:
-3.93%
1M Performance:
-3.91%
6M Performance:
+6.47%
1Y Performance:
+11.85%
1-Day Range:
$74.79
$76.43
1-Week Range:
$74.79
$78.54
52-Week Range:
$64.00
$83.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
75.20 | 44.09B | 5.69B | 1.41B | 577.90M | 6.95 |
|
ABT
Abbott Laboratories
|
134.17 | 231.06B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.50 | 146.66B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.88 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.58 | 120.82B | 34.20B | 4.69B | 5.30B | 3.63 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-24-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-25 | Upgrade | Stifel | Hold → Buy |
| Jan-16-25 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
Bowman & Co S.C. Trims Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Wall Street Zen Downgrades Edwards Lifesciences (NYSE:EW) to Buy - MarketBeat
E. Ohman J or Asset Management AB Takes $2.04 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Intech Investment Management LLC Cuts Position in Edwards Lifesciences Corporation $EW - MarketBeat
Militia Capital Partners LP Sells 60,000 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Edwards Lifesciences Stock: Analyst Estimates & Ratings - MSN
NewEdge Advisors LLC Has $2.39 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Trading Recap: Is Edwards Lifesciences Corporations growth already priced inJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Pacific Capital Partners Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Position Decreased by Seilern Investment Management Ltd - MarketBeat
Capital Asset Advisory Services LLC Takes $452,000 Position in Edwards Lifesciences Corporation $EW - MarketBeat
Glenview Trust co Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat
Exit Recap: Can Edwards Lifesciences Corporation generate free cash flowWeekly Gains Summary & Low Drawdown Momentum Trade Ideas - خودرو بانک
Focus Partners Wealth Acquires 3,891 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Relative Strength Alert For Edwards Lifesciences - Nasdaq
Downgrade Watch: Whats the outlook for Edwards Lifesciences Corporations sectorFed Meeting & Short-Term Swing Trade Alerts - خودرو بانک
Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Jacobs & Co. CA Sells 7,261 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Neville Rodie & Shaw Inc. Has $1.24 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
24,437 Shares in Edwards Lifesciences Corporation $EW Purchased by AG2R LA Mondiale Gestion D Actifs - MarketBeat
Voya Investment Management LLC Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
Acadian Asset Management LLC Acquires 88,099 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
14,705 Shares in Edwards Lifesciences Corporation $EW Bought by Voleon Capital Management LP - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Swedbank AB - MarketBeat
Caxton Associates LLP Invests $370,000 in Edwards Lifesciences Corporation $EW - MarketBeat
Strs Ohio Makes New $9.49 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Howe & Rusling Inc. Purchases 4,351 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
15,468 Shares in Edwards Lifesciences Corporation $EW Acquired by Everstar Asset Management LLC - MarketBeat
Vancity Investment Management Ltd Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Hancock Whitney Corp Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Alliancebernstein L.P. Reduces Position in Edwards Lifesciences Corporation $EW - MarketBeat
MBB Public Markets I LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
Teza Capital Management LLC Sells 71,252 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Polar Asset Management Partners Inc. Has $7.43 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Woodline Partners LP - MarketBeat
AQR Capital Management LLC Grows Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Holdings Lowered by Jacobs Levy Equity Management Inc. - MarketBeat
Amundi Has $213.04 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Picard Announces Appointment of Two New Members to its Board of Directors - GlobeNewswire Inc.
Quarry LP Sells 6,178 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS) - Insider Monkey
Adage Capital Partners GP L.L.C. Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
Graham Capital Management L.P. Makes New $1.08 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Trexquant Investment LP Invests $2.47 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Edmond DE Rothschild Holding S.A. Has $47.94 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Royal Bank of Canada - MarketBeat
Is This the Dip to Buy in Edwards Lifesciences Corporation2025 Earnings Impact & Community Trade Idea Sharing - beatles.ru
Parkman Healthcare Partners LLC Acquires 55,605 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):